X-ZELL facing three start-up competition finals in one week Singapore, November 2020 – Singapore start-up X-ZELL has been nominated for the finals of three high-profile start-up competitions and accelerator programs, all taking place within the same week from 11-18...
X-ZELL closes oversubscribed Seed+ round Singapore, October 2020 – Singapore start-up X-ZELL has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen (DIAG). Ranked among the world’s most innovative health...
X-ZELL selected for prestigious accelerator program Singapore, July 2020 – X-ZELL is one of 20 start-ups to be selected for MedTech Innovator’s 2020 Asia Pacific Accelerator program. Founded in 2013, MedTech Innovator is a Los Angeles-based non-profit organisation...
Next generation Cryoimmunostaining™ coming Singapore, June 2020 – 18 months after premiering at the 2019 Medlab Asia exhibition in Singapore, X-ZELL’s game-changing Cryoimmunostaining™ Suite, comprised of the Cryofixator™ and Cryostainer™, is about to receive a...
X-ZELL part of Galen Growth’s 2020 HealthTech Cohort Singapore, May 2020 – X-ZELL is one of 23 start-ups selected to be part of Galen Growth’s inaugural HealthTech Cohort, an acceleration and networking initiative designed to champion healthcare innovation from across...
Essex Bio-Technology Joins X-ZELL Seed+ Investment Round Singapore/Hong Kong, April 2020 – Rare cell detection specialist X-ZELL has entered into an investment agreement with Essex Bio-Investment, a wholly owned subsidiary of Essex Bio-Technology Ltd (“EssexBio”)....
